These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

679 related articles for article (PubMed ID: 25867861)

  • 1. Dendrimer-nanoparticle conjugates in nanomedicine.
    Parat A; Bordeianu C; Dib H; Garofalo A; Walter A; Bégin-Colin S; Felder-Flesch D
    Nanomedicine (Lond); 2015; 10(6):977-92. PubMed ID: 25867861
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inorganic nanomedicine--part 1.
    Sekhon BS; Kamboj SR
    Nanomedicine; 2010 Aug; 6(4):516-22. PubMed ID: 20417313
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Toxicity of L-DOPA coated iron oxide nanoparticles in intraperitoneal delivery setting - preliminary preclinical study.
    Comănescu MV; Mocanu MA; Anghelache L; Marinescu B; Dumitrache F; Bădoi AD; Manda G
    Rom J Morphol Embryol; 2015; 56(2 Suppl):691-6. PubMed ID: 26429160
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Application of gold nanoparticles in biomedical and drug delivery.
    Daraee H; Eatemadi A; Abbasi E; Fekri Aval S; Kouhi M; Akbarzadeh A
    Artif Cells Nanomed Biotechnol; 2016; 44(1):410-22. PubMed ID: 25229833
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inorganic hollow nanoparticles and nanotubes in nanomedicine Part 2: Imaging, diagnostic, and therapeutic applications.
    Son SJ; Bai X; Lee SB
    Drug Discov Today; 2007 Aug; 12(15-16):657-63. PubMed ID: 17706548
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gold nanoparticle (AuNP)-based drug delivery and molecular imaging for biomedical applications.
    Jeong EH; Jung G; Hong CA; Lee H
    Arch Pharm Res; 2014 Jan; 37(1):53-9. PubMed ID: 24214174
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel water-soluble and pH-responsive anticancer drug nanocarriers: doxorubicin-PAMAM dendrimer conjugates attached to superparamagnetic iron oxide nanoparticles (IONPs).
    Chang Y; Meng X; Zhao Y; Li K; Zhao B; Zhu M; Li Y; Chen X; Wang J
    J Colloid Interface Sci; 2011 Nov; 363(1):403-9. PubMed ID: 21821262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Luminescent nanoparticles and their use for in vitro and in vivo diagnostics.
    Probst J; Dembski S; Milde M; Rupp S
    Expert Rev Mol Diagn; 2012 Jan; 12(1):49-64. PubMed ID: 22133119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design and optimization of lipid-modified poly(amidoamine) dendrimer coated iron oxide nanoparticles as probes for biomedical applications.
    Boni A; Bardi G; Bertero A; Cappello V; Emdin M; Flori A; Gemmi M; Innocenti C; Menichetti L; Sangregorio C; Villa S; Piazza V
    Nanoscale; 2015 Apr; 7(16):7307-17. PubMed ID: 25815711
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gold nanoparticles in nanomedicine: preparations, imaging, diagnostics, therapies and toxicity.
    Boisselier E; Astruc D
    Chem Soc Rev; 2009 Jun; 38(6):1759-82. PubMed ID: 19587967
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tunable synthesis and acetylation of dendrimer-entrapped or dendrimer-stabilized gold-silver alloy nanoparticles.
    Liu H; Shen M; Zhao J; Guo R; Cao X; Zhang G; Shi X
    Colloids Surf B Biointerfaces; 2012 Jun; 94():58-67. PubMed ID: 22326342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peptides and metallic nanoparticles for biomedical applications.
    Kogan MJ; Olmedo I; Hosta L; Guerrero AR; Cruz LJ; Albericio F
    Nanomedicine (Lond); 2007 Jun; 2(3):287-306. PubMed ID: 17716175
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dendrimer-based drug and imaging conjugates: design considerations for nanomedical applications.
    Menjoge AR; Kannan RM; Tomalia DA
    Drug Discov Today; 2010 Mar; 15(5-6):171-85. PubMed ID: 20116448
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemical synthesis and assembly of uniformly sized iron oxide nanoparticles for medical applications.
    Ling D; Lee N; Hyeon T
    Acc Chem Res; 2015 May; 48(5):1276-85. PubMed ID: 25922976
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of integrated cancer nanomedicine in overcoming drug resistance.
    Iyer AK; Singh A; Ganta S; Amiji MM
    Adv Drug Deliv Rev; 2013 Nov; 65(13-14):1784-802. PubMed ID: 23880506
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Why I believe nanoparticles are crucial as a carrier for targeted drug delivery.
    Baker JR
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2013; 5(5):423-9. PubMed ID: 23633301
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nanomedicine for cancer diagnosis and therapy: advancement, success and structure-activity relationship.
    Bhise K; Sau S; Alsaab H; Kashaw SK; Tekade RK; Iyer AK
    Ther Deliv; 2017 Nov; 8(11):1003-1018. PubMed ID: 29061101
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multifunctional nanostructures based on inorganic nanoparticles and oligothiophenes and their exploitation for cellular studies.
    Quarta A; Di Corato R; Manna L; Argentiere S; Cingolani R; Barbarella G; Pellegrino T
    J Am Chem Soc; 2008 Aug; 130(32):10545-55. PubMed ID: 18627147
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Iron oxide nanoparticles for targeted cancer imaging and diagnostics.
    Rosen JE; Chan L; Shieh DB; Gu FX
    Nanomedicine; 2012 Apr; 8(3):275-90. PubMed ID: 21930108
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toxicity of inorganic nanomaterials in biomedical imaging.
    Li J; Chang X; Chen X; Gu Z; Zhao F; Chai Z; Zhao Y
    Biotechnol Adv; 2014; 32(4):727-43. PubMed ID: 24389087
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.